GIM
GILD icon

Groesbeck Investment Management’s Gilead Sciences GILD Stock Holding History

Groesbeck Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,888
Closed -$228K – 94
2016
Q3 		$228K Sell
2,888
-762
-21% -$61.9K 0.17% 102
2016
Q2 		$304K Sell
3,650
-57,135
-94% -$5.07M 0.22% 68
2016
Q1 		$5.58M Sell
60,785
-1,435
-2% -$129K 4% 3
2015
Q4 		$6.3M Sell
62,220
-627
-1% -$65.2K 4.01% 3
2015
Q3 		$6.17M Sell
62,847
-1,224
-2% -$136K 3.89% 3
2015
Q2 		$7.5M Buy
64,071
+12,533
+24% +$1.37M 3.6% 3
2015
Q1 		$5.06M Sell
51,538
-1,615
-3% -$164K 2.45% 13
2014
Q4 		$5.01M Buy
53,153
+700
+1% +$72.4K 2.46% 16
2014
Q3 		$5.58M Buy
52,453
+10,493
+25% +$1.03M 2.66% 6
2014
Q2 		$3.48M Buy
41,960
+36,960
+739% +$2.88M 1.51% 23
2014
Q1 		$354K Hold
5,000
– – 0.16% 68
2013
Q4 		$376K Sell
5,000
-500
-9% -$34.8K 0.16% 66
2013
Q3 		$346K Sell
5,500
-1,200
-18% -$71.7K 0.15% 64
2013
Q2 		$344K Buy
+6,700
New +$349K 0.15% 59

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Groesbeck Investment Management's GILD Position: Q4 2016 in Review

Groesbeck Investment Management sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 2,888 shares — an estimated $228K sold.

Groesbeck Investment Management first reported a position in GILD in Q2 2013 and held it in 14 quarters. The position peaked at $7.5M in Q2 2015. 1,573 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Groesbeck Investment Management reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Groesbeck Investment Management sold 2,888 Gilead Sciences shares in Q4 2016, an estimated $228K.
  • Groesbeck Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 14 quarters.
  • Groesbeck Investment Management's Gilead Sciences position peaked at $7.5M in Q2 2015.
  • 1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Groesbeck Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.